共 50 条
- [21] Lubiprostone In Constipation-Predominant Irritable Bowel Syndrome [J]. DRUGS, 2009, 69 (09) : 1229 - 1237
- [22] LubiprostoneIn Constipation-Predominant Irritable Bowel Syndrome [J]. Drugs, 2009, 69 : 1229 - 1237
- [23] Colonoscopic features of functional constipation and constipation-predominant irritable bowel syndrome (IBS-C) [J]. NEUROGASTROENTEROLOGY AND MOTILITY, 2011, 23 : 21 - 22
- [28] Clinical and anorectal manometry profile of patients with functional constipation and constipation-predominant irritable bowel syndrome [J]. Indian Journal of Gastroenterology, 2019, 38 : 211 - 219
- [29] Tegaserod for constipation-predominant irritable bowel syndrome [J]. PHARMACOTHERAPY, 2007, 27 (02): : 267 - 277
- [30] Increased psychological distress and somatization in patients with irritable bowel syndrome compared with functional diarrhea or functional constipation, based on Rome IV criteria [J]. NEUROGASTROENTEROLOGY AND MOTILITY, 2021, 33 (10):